Zimmer Biomet just threw down the robotic gauntlet, upgrading its game by acquiring Monogram Technologies to close tech gaps and directly challenge Stryker’s MAKO dominance. This bold strategy mimics ...

Comparing Stryker's Short Interest Against Its Peers Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another ...

Additionally, Irisin reduces ROS levels and decreases SYK expression, thereby inhibiting the inflammatory response. Irisin improves the learning and spatial memory abilities of TBI mice and reduces ...

A research team has developed a groundbreaking deep learning-based method for analyzing the cytoskeleton -- the structural framework inside cells -- more accurately and efficiently than ever ...

STRYKER CORP (SYK) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 66% based on the firm’s underlying fundamentals and the stock’s ...

The cytoskeleton is a cellular scaffolding system whose functions include maintenance of cellular shape, enabling cellular migration, division, intracellular transport, signaling and membrane ...

Recent studies provide new insights into signaling by mutant KRAS, inhibitors of which have provided modest benefits for patients.

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for developing effective treatments.

Not only have researchers identified how a common cellular protein affects aging, but they’ve tweaked the genes that produce it in fruit flies, extending healthy lifespan by 25% to 30%. The ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...